Form 4: OptimizeRx CFO Boosts Stake via RSU Conversion

OptimizeRx's Chief Finance & Strategy Officer, Edward Stelmakh, converted restricted stock units into common stock, increasing his direct beneficial ownership.

Summary

• Edward Stelmakh, Chief Finance & Strategy Officer of OptimizeRx Corp (OPRX), reported changes in his beneficial ownership.
• On October 3, 2025, he acquired 16,623 shares of common stock through the conversion of restricted stock units (RSUs).
• Concurrently, 4,406 shares were disposed of at a price of $18.75 per share to satisfy tax withholding obligations related to the RSU vesting.
• Following these transactions, Stelmakh directly beneficially owns 122,981 shares of OptimizeRx Corp common stock.
• The RSUs convert on a one-for-one basis and vest in three equal annual installments, with the first vesting occurring on October 3, 2023.

Sentiment

Score: 7

Explanation: The Chief Finance & Strategy Officer increased his direct beneficial ownership of the company's common stock through the conversion of restricted stock units, which can be viewed as a positive signal of management's confidence and alignment with shareholder interests.

Positives

• Chief Finance & Strategy Officer Edward Stelmakh increased his direct beneficial ownership of OptimizeRx Corp common stock by a net of 12,217 shares (16,623 acquired minus 4,406 disposed for tax).
• The acquisition of shares through RSU conversion demonstrates continued vesting of equity compensation, aligning management's interests with shareholders.

Negatives

• 4,406 shares were disposed of to cover tax withholding obligations, which is a standard practice for RSU vesting and not indicative of a negative outlook.

Future Outlook

The restricted stock units vest in three equal annual installments, indicating future conversions of RSUs into common stock for the reporting person.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation, which is common across all industries for publicly traded companies. It does not provide specific industry-related insights.

Comparison to Industry Standards

• The vesting of restricted stock units and subsequent disposition of shares for tax withholding are standard practices for executive equity compensation plans across publicly traded companies. No specific comparable companies or projects are mentioned in this filing.

Stakeholder Impact

• Shareholders: Increased insider ownership may signal management confidence in the company's future performance.
• Employees: The vesting of RSUs is a standard component of executive compensation, potentially reinforcing the company's compensation structure.

Next Steps

• Future annual installments of the restricted stock units will vest, leading to further conversions into common stock.

Key Dates

Keywords

OptimizeRx, OPRX, Edward Stelmakh, Form 4, insider transaction, restricted stock units, RSU conversion, executive compensation, beneficial ownership